WO2000033787A2 - Composition cosmetique deodorante - Google Patents
Composition cosmetique deodorante Download PDFInfo
- Publication number
- WO2000033787A2 WO2000033787A2 PCT/FR1999/002887 FR9902887W WO0033787A2 WO 2000033787 A2 WO2000033787 A2 WO 2000033787A2 FR 9902887 W FR9902887 W FR 9902887W WO 0033787 A2 WO0033787 A2 WO 0033787A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition according
- amino acid
- chosen
- acid
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
- A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Definitions
- the present invention relates to a deodorant composition, preferably a cosmetic composition, comprising at least one selected inhibitor compound of amino acid transformation enzyme, the use of these compositions for topical human application and the use of an inhibitor.
- selected amino acid transformation enzyme as deodorant active
- the antiperspirant substances have the effect of limiting the sweat flow They generally consist of aluminum salts which, on the one hand, are irritating to the skin and which, on the other hand, reduce the sweat flow by modifying the physiology skin, which is not satisfactory
- TRICLOSAN 5-chloro-2- (2,4-d ⁇ chlorophenoxy) phenol
- inhibitors of certain enzymes have the property of preventing the development of bad odors, without the drawbacks of the active substances previously used in deodorant compositions, and with the advantage of being more effective and of being able to be selected to be easily formulated, in particular in cosmetic water-based compositions for human topical application
- the present invention thus firstly relates to a new deodorant composition
- a new deodorant composition comprising an effective amount of at least one inhibitor of an amino acid transformation enzyme which is not an inhibitor of ⁇ -lyase, said enzyme being chosen from the group formed by
- It also relates to the use of at least one inhibitor of this type as a deodorant cosmetic active agent, in particular as an agent inhibiting the development of human axillary odors in the manufacture of cosmetic or dermatological products. It finally relates to a process for desodonsation using said composition, and more particularly a process for treating human axillary odors, consisting in applying to the axillary surface an effective amount of said composition
- the term "effective amount of enzyme inhibitor” means a sufficient amount of enzyme inhibitor, in the dosage form used, to produce, after application, a satisfactory deodorant effect.
- deodorant effect is intended to mean an activity which makes it possible to substantially reduce or even eliminate unpleasant odors and more particularly body odors.
- hydrolases in accordance with the invention there may be mentioned in particular
- inhibitors of these enzymes which can be used according to the invention, mention may be made, in particular of the following compounds
- the amino acid transformation enzyme inhibitor is generally present in weight proportions, calculated by weight relative to the total weight of the composition, ranging from approximately 0.001 to approximately 20%, preferably ranging from approximately 0.01 to approximately 5%.
- the deodorant compositions of the present invention may also comprise other conventional deodorant active agents in addition to the compounds of the invention.
- deodorant active agents can be chosen, for example, from water-soluble zinc salts, such as for example zinc pyrrolidone carboxylate (more commonly called peeled zinc pidolate), zinc sulfate, zinc chloride, zinc lactate, zinc gluconate and zinc phenolsulfonate; aluminum salts, such as for example aluminum chloride and aluminum hydroxyhalides; zirconium salts, such as, for example, zirconium oxide salts, hydroxyzirconyl salts; metal complexes based on Aluminum or Zirconium; bactericides.
- water-soluble zinc salts such as for example zinc pyrrolidone carboxylate (more commonly called peeled zinc pidolate), zinc sulfate, zinc chloride, zinc lactate, zinc gluconate and zinc phenolsulfonate
- aluminum salts such as for example aluminum chloride and aluminum hydroxyhalides
- zirconium salts such as, for example, zirconium oxide salts, hydroxyzircon
- the deodorant compositions of the present invention are conventionally formulated according to the applications for which they are intended. When they are intended for cosmetic use, they are more particularly formulated in a cosmetically acceptable vehicle which can in particular be essentially aqueous, and contain monoalcohols in j-C preferably ethanol to accelerate the evaporation of the product.
- the monoalcohols are generally present in amounts ranging from 15 to 50%, preferably from 20 to 45% and even more preferably from 25 to 35%.
- compositions according to the invention can also be formulated in water-in-oil, oil-in-water emulsion, or in triple water-in-oil-in-water emulsion (such emulsions are known and described for example by C FOX in “Cosmetics and Toi- letries” - November 1986 - Vol 101 - pages 101-1 12).
- compositions of the invention may also comprise cosmetic adjuvants chosen from fatty substances, organic solvents, gelling agents, emollients, softeners, antioxidants, opacifiers, stabilizers, silicones, anti-foaming agents, moisturizing agents, vitamins, perfumes, preservatives, surfactants, fillers, sequestrants, polymers, propellants, basifying or acidifying agents, dyes, perfumes, dyes, pigments, thickening agents, or any other ingredient usually used in cosmetics.
- the surfactants are chosen from nonionic, amphoteric, canonical or anionic surfactants or their mixtures.
- the fatty substances can consist of an oil or a wax or their mixture, petroleum jelly, paraffin, lanolin, hydrogenated lanolin, acetylated lanolin; they also include fatty acids, fatty alcohols such as lauric, cetyl, myoristic, stearic, palmitic, oleic alcohol as well as 2-octyldodecanol, esters of fatty acids such as glycerol monostearate, polyethylene glycol monostearate, isopropyl myististate, isopropyl adipate, isopropyl palmitate, octyl palmitate, C 12 -C 15 fatty alcohol benzoates (FINSOLV TN from FINETEX) , polyoxypropylenated myristic alcohol with 3 moles of propylene oxide (WITCONOL APM from WITCO), C 6 -C 18 fatty acid triglycerides such as caprylic / capric acid triglycerides.
- oils are chosen from animal, vegetable, mineral or synthetic oils and in particular hydrogenated palm oil, hydrogenated castor oil, linseed oil, paraffin oil, Purcellin oil (stearyl octanoate), silicone oils and isoparaffins.
- the waxes are chosen from animal, fossil, vegetable, mineral or synthetic waxes. Mention may in particular bees beeswaxes, Camauba, Candlilla, sugar cane, Japanese waxes, ozokerites, Montan wax, microcrystalline waxes, paraffins, waxes and silicone resins.
- the thickeners are preferably nonionic or anionic.
- the nonionic thickeners can be chosen from guar gums and modified or unmodified celluloses such as hydroxypropylated guar gum. Cetylhydroxyethylcellulose, silicas such as, for example, Bentone Gel MiO sold by the company NL INDUSTRIES or Veegum Ultra, sold by the company POLYPLASTIC.
- the anionic thickeners can be chosen from crosslinked polyacrylic acids or homo or copolymers of acrylamido propane sulfonic acid.
- emollients which contribute to a soft, dry feeling, non-sticky when the composition is applied to the skin.
- emollients can be chosen from products of the volatile silicone type, non-volatile silicones and other non-volatile emollients.
- the emollients are present in proportions ranging from 20 to 80%, preferably from 25 to 60% and even more preferably from 35 to 55%.
- Volatile silicones are defined in a known manner as volatile compounds at room temperature. Among these compounds, mention may be made of cyclic and linear volatile silicones of the dimethylsiloxane type, the chains of which comprise from 3 to 9 silicone residues. Preferably, cyclomethicones D4 or D5 are chosen.
- Non-volatile silicones are defined in a known manner as compounds with low vapor pressure at room temperature.
- polyalkylsiloxanes in particular linear polyalkylsiloxanes such as, for example, linear polydimethylsiloxanes, or dimethicones, sold by the company Dow Corning under the name of "Dow Corning 200 Fluid”
- polyalkylarylsiloxanes such as, for example, polymethylphenylsiloxanes, sold by the company Dow Corning under the name of "Dow Corning 556 Fluid”
- polyether and siloxane copolymers such as, for example, dimethicone copolyols.
- nonvolatile emollients useful in the present invention include for example: hydrocarbon-based derivatives, mineral oils, fatty alcohols, alcohol esters of C 3 -C 18 acids with C 3 -C 18 , esters of benzoic acid with C 12 -C 18 alcohols and their mixtures, C 2 -C 6 polyols preferably chosen from glycerol, propylene glycol or sorbitol, polymers of polalkylene glycol.
- the pH of the compositions of the invention is between 2 and 12 and preferably between 4 and 10.
- the deodorant compositions according to the invention may be in the form of lotions, creams or of fluid gels distributed in aerosol spray, in pump bottle or in roll-on, in the form of thick creams distributed in tubes and in the form of sticks, and contain in this regard the ingredients and propellants generally used in this type of products and well known skilled in the art, provided that they do not interfere with the enzyme inhibitors described in the present invention.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002353721A CA2353721A1 (fr) | 1998-12-08 | 1999-11-23 | Composition cosmetique deodorante |
EP99956129A EP1137393A2 (fr) | 1998-12-08 | 1999-11-23 | Composition cosmetique deodorante |
AU12795/00A AU1279500A (en) | 1998-12-08 | 1999-11-23 | Deodorant cosmetic composition |
BR9916947-9A BR9916947A (pt) | 1998-12-08 | 1999-11-23 | Composição cosmética desodorante contendo um composto inibidor de enzima de transformação dos ácidos aminados, processo para tratar os odores axilares humanos e uso de um composto inibidor de enzima de transformação dos ácidos aminados |
JP2000586282A JP2002531474A (ja) | 1998-12-08 | 1999-11-23 | デオドラント化粧品組成物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR98/15477 | 1998-12-08 | ||
FR9815477A FR2786690A1 (fr) | 1998-12-08 | 1998-12-08 | Composition cosmetique deodorante |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000033787A2 true WO2000033787A2 (fr) | 2000-06-15 |
WO2000033787A3 WO2000033787A3 (fr) | 2000-10-19 |
Family
ID=9533715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1999/002887 WO2000033787A2 (fr) | 1998-12-08 | 1999-11-23 | Composition cosmetique deodorante |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1137393A2 (fr) |
JP (1) | JP2002531474A (fr) |
AU (1) | AU1279500A (fr) |
BR (1) | BR9916947A (fr) |
CA (1) | CA2353721A1 (fr) |
FR (1) | FR2786690A1 (fr) |
WO (1) | WO2000033787A2 (fr) |
ZA (1) | ZA200104481B (fr) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1058529A1 (fr) * | 1998-02-03 | 2000-12-13 | The Gillette Company | Composition de deodorant contenant un d-aminoacide |
DE10136077A1 (de) * | 2001-07-25 | 2003-02-13 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einer Kombination von Kreatinin und/oder Kreatininderivaten mit Kreatin und/oder seinen Derivaten |
DE10136076A1 (de) * | 2001-07-25 | 2003-02-13 | Beiersdorf Ag | Verwendung von Kreatinin und/oder Kreatininderivaten in kosmetischen oder dermatologischen Zubereitungen |
DE102005023636A1 (de) * | 2005-05-19 | 2006-11-23 | Beiersdorf Ag | Wirkstoffkombinationen aus Glucosylglyceriden und Kreatin und / oder Kreatinin |
US20100211137A1 (en) * | 2007-06-29 | 2010-08-19 | Welskin Co., Ltd. | Acne therapeutic agent and sebum secernent inhibitor which comprise indole-3-alkylcarbo xylicacid, and kits for photodynamic therapy containing the same |
US10682534B2 (en) | 2003-11-26 | 2020-06-16 | Beiersdorf, Ag | Cosmetic preparations containing creatine and/or creatinine and organic thickeners |
US10888719B2 (en) | 2003-11-26 | 2021-01-12 | Beiersdorf Ag | Active substance combination of creatine and/or creatinine and phenoxyethanol |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI473624B (zh) * | 2009-09-14 | 2015-02-21 | Shiseido Co Ltd | D-methionine and its salts are used in the manufacture of methods for reducing the UV damage composition |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4089942A (en) * | 1976-01-29 | 1978-05-16 | L'oreal | Deodorant composition and process |
US4883651A (en) * | 1987-05-14 | 1989-11-28 | Holger Meyer | Deodorant |
WO1991005541A1 (fr) * | 1989-10-10 | 1991-05-02 | The Gillette Company | Inhibiteurs a base d'une amino acide beta-lyase enzyme utilises comme deodorants |
EP0483427A1 (fr) * | 1990-11-01 | 1992-05-06 | The Procter & Gamble Company | Composition déodorante et méthode de déodorisation à l'aide d'amine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5643559A (en) * | 1991-10-30 | 1997-07-01 | Colgate-Palmolive Company | Deodorant compositions comprising inhibitors of odor-producing axillary bacterial exoenzymes |
US5516511A (en) * | 1994-05-06 | 1996-05-14 | The Procter & Gamble Company | Antiperspirant gel compositions comprising chelators |
-
1998
- 1998-12-08 FR FR9815477A patent/FR2786690A1/fr not_active Withdrawn
-
1999
- 1999-11-23 ZA ZA200104481A patent/ZA200104481B/en unknown
- 1999-11-23 WO PCT/FR1999/002887 patent/WO2000033787A2/fr not_active Application Discontinuation
- 1999-11-23 JP JP2000586282A patent/JP2002531474A/ja not_active Withdrawn
- 1999-11-23 EP EP99956129A patent/EP1137393A2/fr not_active Withdrawn
- 1999-11-23 CA CA002353721A patent/CA2353721A1/fr not_active Abandoned
- 1999-11-23 BR BR9916947-9A patent/BR9916947A/pt not_active IP Right Cessation
- 1999-11-23 AU AU12795/00A patent/AU1279500A/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4089942A (en) * | 1976-01-29 | 1978-05-16 | L'oreal | Deodorant composition and process |
US4883651A (en) * | 1987-05-14 | 1989-11-28 | Holger Meyer | Deodorant |
WO1991005541A1 (fr) * | 1989-10-10 | 1991-05-02 | The Gillette Company | Inhibiteurs a base d'une amino acide beta-lyase enzyme utilises comme deodorants |
EP0483427A1 (fr) * | 1990-11-01 | 1992-05-06 | The Procter & Gamble Company | Composition déodorante et méthode de déodorisation à l'aide d'amine |
Non-Patent Citations (2)
Title |
---|
ZOLLNER H.: "HANDBOOK OF ENZYME INHIBITORS, 2ND REVISED AND ENLARGED EDITION PART A" 1993 , VCH VERLAGSGESELLSCHAFT , WEINHEIM XP002130614 page 76-77 page 78 page 85 * |
ZOLLNER H.: "HANDBOOK OF ENZYME INHIBITORS, 2ND REVISED AND ENLARGED EDITION PART B" 1993 , VCH VERLAGSGESELLSCHAFT , WEINHEIM XP002130613 page 617 page 631 page 826 -page 827 page 886 page 965 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1058529A1 (fr) * | 1998-02-03 | 2000-12-13 | The Gillette Company | Composition de deodorant contenant un d-aminoacide |
EP1058529A4 (fr) * | 1998-02-03 | 2001-09-19 | Gillette Co | Composition de deodorant contenant un d-aminoacide |
DE10136077A1 (de) * | 2001-07-25 | 2003-02-13 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einer Kombination von Kreatinin und/oder Kreatininderivaten mit Kreatin und/oder seinen Derivaten |
DE10136076A1 (de) * | 2001-07-25 | 2003-02-13 | Beiersdorf Ag | Verwendung von Kreatinin und/oder Kreatininderivaten in kosmetischen oder dermatologischen Zubereitungen |
US10682534B2 (en) | 2003-11-26 | 2020-06-16 | Beiersdorf, Ag | Cosmetic preparations containing creatine and/or creatinine and organic thickeners |
US10888719B2 (en) | 2003-11-26 | 2021-01-12 | Beiersdorf Ag | Active substance combination of creatine and/or creatinine and phenoxyethanol |
DE102005023636A1 (de) * | 2005-05-19 | 2006-11-23 | Beiersdorf Ag | Wirkstoffkombinationen aus Glucosylglyceriden und Kreatin und / oder Kreatinin |
US20100211137A1 (en) * | 2007-06-29 | 2010-08-19 | Welskin Co., Ltd. | Acne therapeutic agent and sebum secernent inhibitor which comprise indole-3-alkylcarbo xylicacid, and kits for photodynamic therapy containing the same |
Also Published As
Publication number | Publication date |
---|---|
AU1279500A (en) | 2000-06-26 |
CA2353721A1 (fr) | 2000-06-15 |
WO2000033787A3 (fr) | 2000-10-19 |
BR9916947A (pt) | 2002-02-19 |
ZA200104481B (en) | 2002-01-16 |
JP2002531474A (ja) | 2002-09-24 |
FR2786690A1 (fr) | 2000-06-09 |
EP1137393A2 (fr) | 2001-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0858797B1 (fr) | Composition déodorante comprenant un dendrimère | |
EP1029530A1 (fr) | Utilisation de dérivés substitués en 3 du stilbene comme actifs déodorants dans les compositions cosmétiques | |
CA2109424C (fr) | Composition topique anti-radicaux libres a base de superoxyde-dismutase et d'un derive phosphonique | |
FR2781149A1 (fr) | Composition deodorante contenant un sel d'alun | |
EP0913147B1 (fr) | Système à base de dérivé d'acide phosphonique et de métabisulfite pour stabiliser l'acide ascorbique | |
FR2717385A1 (fr) | Composition cosmétique contenant en association une superoxyde dismutase et une porphyrine. | |
FR2863490A1 (fr) | Composition deorante du type emulsion huile-dans-eau contenant un melange d'alkylpolyglycoside et d'alcool gras et un polyether polyurethane non-ionique associatif | |
FR2871376A1 (fr) | Composition cosmetique comprenant comme agent anti-transpirant un polymere hydrosoluble floculant; procede de traitement de la transpiration et des odeurs corporelles | |
WO2000033787A2 (fr) | Composition cosmetique deodorante | |
EP1486199B1 (fr) | Composition déodorante aérosol alcoolique contenant le salicylate de zinc | |
EP1541122B1 (fr) | Composition cosmétique déodorante comprenant l'association du pidolate de zinc et d'un sel d'aluminium anti-transpirant | |
EP1151745A1 (fr) | Composition sous forme d'émulsion eau-dans-huile et ses utilisations cosmétiques | |
WO2003002081A1 (fr) | Composition contenant un derive d'hydroxydiphenyl ether inhibant le developpement des odeurs corporelles | |
WO2002034222A1 (fr) | Utilisation de derives du 1,3-diphenylpropane comme actifs inhibant le developpement des odeurs corporelles dans les compositions cosmetiques | |
EP0998909A1 (fr) | Composition déodorante | |
WO2003002072A1 (fr) | Compositions contenant un derive d'hyroxydiphenyl ether inhibant le developpemment des odeurs corporelles | |
EP1190703A1 (fr) | Composition à base de glycoglycéride et ses utilisations notamment cosmétiques | |
WO2003002078A1 (fr) | Compositions contenant un derive d'hydroxydiphenyl ether inhibant le developpement des odeurs corporelles | |
FR2961690A1 (fr) | Utilisation de monosaccharide mannose a titre d'agent de conditionnement de la peau | |
EP1276454A2 (fr) | Sels de manganese divalent pour reduire l'odeur resultant de la decomposition bacterienne de la sueur humaine | |
FR2789899A1 (fr) | Extrait de metrosideros et son utilisation comme agent antimicrobien dans une composition dermatologique ou cosmetique | |
FR3118873A1 (fr) | Composition pour conditionner les matieres keratineuses | |
FR2838644A1 (fr) | Utilisation de derives de la 1,7-bisphenyl heptane-3,5-dione comme actifs inhibant le developpement des odeurs corporelles dans les compositions cosmetiques | |
FR2789897A1 (fr) | Extrait de cryptocarya et son utilisation comme agent antimicrobien dans une composition dermatologique ou cosmetique | |
FR2789898A1 (fr) | Agent antimicrobien a base d'extrait de chlorophora et son utilisation dans une composition dermatologique ou cosmetique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref country code: AU Ref document number: 2000 12795 Kind code of ref document: A Format of ref document f/p: F |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999956129 Country of ref document: EP Ref document number: 2001/04481 Country of ref document: ZA Ref document number: 200104481 Country of ref document: ZA |
|
ENP | Entry into the national phase |
Ref document number: 2353721 Country of ref document: CA Ref country code: CA Ref document number: 2353721 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12795/00 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 586282 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09857622 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1999956129 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999956129 Country of ref document: EP |